Literature DB >> 29451006

Different Indexes of Glycemic Variability as Identifiers of Patients with Risk of Hypoglycemia in Type 2 Diabetes Mellitus.

Ana M Gómez1,2, Oscar M Muñoz1,2, Alejandro Marin1,2, Maria Camila Fonseca1,2, Martin Rondon1, María Alejandra Robledo Gómez1, Andrei Sanko1, Dilcia Lujan3, Maira García-Jaramillo2,4, Fabian Mauricio León Vargas2,5.   

Abstract

INTRODUCTION: Recent publications frequently introduce new indexes to measure glycemic variability (GV), quality of glycemic control, or glycemic risk; however, there is a lack of evidence supporting the use of one particular parameter, especially in clinical practice.
METHODS: A cohort of type 2 diabetes mellitus (T2DM) patients in ambulatory care were followed using continuous glucose monitoring sensors (CGM). Mean glucose (MG), standard deviation, coefficient of variation (CV), interquartile range, CONGA1, 2, and 4, MAGE, M value, J index, high blood glucose index, and low blood glucose index (LBGI) were estimated. Hypoglycemia incidence (<54 mg/dl) was calculated. Area under the curve (AUC) was determined for different indexes as identifiers of patients with risk of hypoglycemia (IRH). Optimal cutoff thresholds were determined from analysis of the receiver operating characteristic curves.
RESULTS: CGM data for 657 days from 140 T2DM patients (4.69 average days per patient) were analyzed. Hypoglycemia was present in 50 patients with 144 hypoglycemic events in total (incidence rate of 0.22 events per patient/day). In the multivariate analysis, both CV (OR 1.20, 95% CI 1.12-1.28, P < .001) and LBGI (OR 4.83, 95% CI 2.41-9.71, P < .001) were shown to have a statistically significant association with hypoglycemia. The highest AUC were for CV (0.84; 95% CI 0.77-0.91) and LBGI (0.95; 95% CI 0.92-0.98). The optimal cutoff threshold for CV as IRH was 34%, and 3.4 for LBGI.
CONCLUSION: This analysis shows that CV can be recommended as the preferred parameter of GV to be used in clinical practice for T2DM patients. LBGI is the preferred IRH between glycemic risk indexes.

Entities:  

Keywords:  continuous glucose monitoring; glucose variability; hypoglycemia; type 2 diabetes

Mesh:

Substances:

Year:  2018        PMID: 29451006      PMCID: PMC6134628          DOI: 10.1177/1932296818758105

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  28 in total

1.  Classification accuracy and cut point selection.

Authors:  Xinhua Liu
Journal:  Stat Med       Date:  2012-02-03       Impact factor: 2.373

2.  Relationships among different glycemic variability indices obtained by continuous glucose monitoring.

Authors:  Yoshifumi Saisho; Chihiro Tanaka; Kumiko Tanaka; Rachel Roberts; Takayuki Abe; Masami Tanaka; Shu Meguro; Junichiro Irie; Toshihide Kawai; Hiroshi Itoh
Journal:  Prim Care Diabetes       Date:  2014-11-16       Impact factor: 2.459

3.  Evaluation of a new measure of blood glucose variability in diabetes.

Authors:  Boris P Kovatchev; Erik Otto; Daniel Cox; Linda Gonder-Frederick; William Clarke
Journal:  Diabetes Care       Date:  2006-11       Impact factor: 19.112

Review 4.  Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2016-11-21       Impact factor: 19.112

5.  Clinical interpretation of indices of quality of glycemic control and glycemic variability.

Authors:  David Rodbard
Journal:  Postgrad Med       Date:  2011-07       Impact factor: 3.840

6.  Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.

Authors:  M Shichiri; H Kishikawa; Y Ohkubo; N Wake
Journal:  Diabetes Care       Date:  2000-04       Impact factor: 19.112

7.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

8.  Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin-treated type 1 and type 2 diabetes: the global HAT study.

Authors:  K Khunti; S Alsifri; R Aronson; M Cigrovski Berković; C Enters-Weijnen; T Forsén; G Galstyan; P Geelhoed-Duijvestijn; M Goldfracht; H Gydesen; R Kapur; N Lalic; B Ludvik; E Moberg; U Pedersen-Bjergaard; A Ramachandran
Journal:  Diabetes Obes Metab       Date:  2016-06-20       Impact factor: 6.577

9.  Glucose variability.

Authors:  F John Service
Journal:  Diabetes       Date:  2013-05       Impact factor: 9.461

Review 10.  Glycemic Variability: How Do We Measure It and Why Is It Important?

Authors:  Sunghwan Suh; Jae Hyeon Kim
Journal:  Diabetes Metab J       Date:  2015-08       Impact factor: 5.376

View more
  9 in total

1.  Randomized Study Comparing Vildagliptin vs Glibenclamide on Glucose Variability and Endothelial Function in Patients with Type 2 Diabetes Mellitus and Hypertension.

Authors:  Luciana Neves Cosenso-Martin; Lais Yumi Takaoka; Jose Fernando Vilela-Martin
Journal:  Diabetes Metab Syndr Obes       Date:  2020-09-15       Impact factor: 3.168

Review 2.  Glycemic variability: adverse clinical outcomes and how to improve it?

Authors:  Zheng Zhou; Bao Sun; Shiqiong Huang; Chunsheng Zhu; Meng Bian
Journal:  Cardiovasc Diabetol       Date:  2020-07-04       Impact factor: 9.951

3.  Exposure to recurrent hypoglycemia alters hippocampal metabolism in treated streptozotocin-induced diabetic rats.

Authors:  Neelesh Dewan; Vibha Shukla; Ashish K Rehni; Kevin B Koronowski; Kyle D Klingbeil; Holly Stradecki-Cohan; Timothy J Garrett; Tatjana Rundek; Miguel A Perez-Pinzon; Kunjan R Dave
Journal:  CNS Neurosci Ther       Date:  2019-07-07       Impact factor: 5.243

Review 4.  Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications.

Authors:  Bao Sun; Zhiying Luo; Jiecan Zhou
Journal:  Cardiovasc Diabetol       Date:  2021-01-07       Impact factor: 9.951

5.  Clinical Factors Associated with High Glycemic Variability Defined by Coefficient of Variation in Patients with Type 2 Diabetes.

Authors:  A M Gómez; D C Henao-Carillo; L Taboada; O Fuentes; O Lucero; A Sanko; M A Robledo; O Muñoz; M Rondón; M García-Jaramillo; F León-Vargas
Journal:  Med Devices (Auckl)       Date:  2021-03-31

6.  The association between hypoglycemia and glycemic variability in elderly patients with type 2 diabetes: a prospective observational study.

Authors:  Takahisa Handa; Akinobu Nakamura; Aika Miya; Hiroshi Nomoto; Hiraku Kameda; Kyu Yong Cho; So Nagai; Narihito Yoshioka; Hideaki Miyoshi; Tatsuya Atsumi
Journal:  Diabetol Metab Syndr       Date:  2021-04-01       Impact factor: 3.320

7.  Defining the target value of the coefficient of variation by continuous glucose monitoring in Chinese people with diabetes.

Authors:  Yifei Mo; Xiaojing Ma; Jingyi Lu; Yun Shen; Yufei Wang; Lei Zhang; Wei Lu; Wei Zhu; Yuqian Bao; Jian Zhou
Journal:  J Diabetes Investig       Date:  2020-11-27       Impact factor: 4.232

8.  Reduction of glycemic variability with Degludec insulin in patients with unstable diabetes.

Authors:  Diana Cristina Henao-Carrillo; Oscar M Muñoz; Ana M Gómez; Martín Rondón; Christian Colón; L Chica; Claudia Rubio; Fabián León-Vargas; Maria Alejandra Calvachi; Ana María Perea
Journal:  J Clin Transl Endocrinol       Date:  2018-03-26

9.  Retrospective study of glycemic variability, BMI, and blood pressure in diabetes patients in the Digital Twin Precision Treatment Program.

Authors:  Paramesh Shamanna; Mala Dharmalingam; Rakesh Sahay; Jahangir Mohammed; Maluk Mohamed; Terrence Poon; Nathan Kleinman; Mohamed Thajudeen
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.